Aviceda Therapeutics Announces Strategic Partnership with Queen’s University Belfast (QUB)
Digital Health Global
APRIL 10, 2023
Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It Its mission is to improve patient outcomes, train the next generation of scientists and clinicians, and enhance the competitiveness of the UK life sciences sector.
Let's personalize your content